Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Clinical trial NCT01935934 · COMPLETED

Trial details

NCT number: NCT01935934
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Mixed Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Metastatic Endometrioid Adenocarcinoma Recurrent Malignant Uterine Corpus Neoplasm Stage IV Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Uterine Corpus Carcinosarcoma

Start date: 2013-05-08
Primary completion: 2019-09-12
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.